Welcome to our dedicated page for Alexandria Real Estate Eq news (Ticker: ARE), a resource for investors and traders seeking the latest updates and insights on Alexandria Real Estate Eq stock.
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is an S&P 500 life science REIT that regularly issues detailed updates on its operations, leasing activity, capital allocation, and Megacampus™ developments. The news flow for Alexandria reflects its role as an owner, operator, and developer of Class A/A+ properties in major life science innovation clusters, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.
On this page, readers can follow company announcements about quarterly and year-end operating and financial results, including metrics such as funds from operations (FFO), net operating income, occupancy, leasing volume, and development pipeline progress. Alexandria frequently reports on large leases, such as long-term build-to-suit research hubs on its Campus Point and One Alexandria Square Megacampus ecosystems, as well as tenant collections, rental rate changes, and same property performance.
News items also cover Board decisions on quarterly cash dividends, explanations of dividend strategy in the context of liquidity and balance sheet strength, and authorizations or extensions of common stock repurchase programs. Investors can review how the company describes its capital recycling strategy, including dispositions of non-core assets, land sales, and partial interest sales intended to fund construction and manage leverage.
Beyond financial reporting, Alexandria’s releases highlight partnerships and recognitions within the broader life science ecosystem. Examples include strategic collaborations with large pharmaceutical companies on shared innovation hubs and awards from organizations such as the Foundation for the National Institutes of Health recognizing contributions to biomedical innovation. For ongoing context around ARE’s performance, strategy, and sector role, this news feed aggregates the company’s official press releases and related disclosures.
On October 18, 2021, Alexandria Venture Investments, a part of Alexandria Real Estate Equities (NYSE: ARE), was named the most active biopharma corporate investor by new deal volume for the fourth consecutive year. The recognition is part of Silicon Valley Bank's Healthcare Investments and Exits: Mid-Year 2021 Report. Alexandria also ranked as the top new Series A investor in biopharma. The firm has a market capitalization of $36.3 billion and has invested in notable companies such as GRAIL and Thrive Earlier Detection, enhancing its role in advancing health science.
Summary not available.
On September 30, 2021, Alexandria Real Estate Equities (NYSE: ARE) announced its collaboration with Moderna to develop a new 462,000 RSF headquarters and R&D facility at 325 Binney Street, Cambridge. This cutting-edge building, designed to be the most sustainable laboratory in Cambridge, aims for net-zero energy consumption and various environmental certifications. Construction is underway, with completion expected in 2023, supporting Moderna's growth in mRNA medicines. Alexandria has expanded its asset base to approximately 15 million square feet in Greater Boston, emphasizing its role in the life science ecosystem.
Moderna, Inc. (NASDAQ: MRNA) has announced plans to invest in a new 462,000 sq. ft. science center in Cambridge, Massachusetts, aiming for LEED Zero certification. This facility will support its mRNA therapeutics and vaccines, focusing on sustainability and collaboration. Construction has begun, with phased move-in expected in 2023. Alexandria Real Estate Equities (NYSE: ARE) is the development partner, while Jones Lang LaSalle (NYSE: JLL) facilitated the site selection. Moderna's pipeline includes 37 programs, 22 of which are in clinical studies.
Alexandria Real Estate Equities (NYSE: ARE) announced that OneFifteen, a non-profit healthcare ecosystem for opioid addiction recovery, received an honorable mention in Fast Company's 2021 Innovation by Design Awards. This award highlights Alexandria's role in tackling the opioid crisis, which caused over 95,000 deaths in the U.S. by February 2021. The OneFifteen campus in Dayton, Ohio, developed in partnership with Verily, features comprehensive addiction care and has helped over 3,500 patients since 2019. This recognition emphasizes Alexandria's commitment to innovative solutions in public health.
Summary not available.
On September 10, 2021, Alexandria Real Estate Equities (NYSE: ARE) announced that its executive chairman, Joel S. Marcus, received the Distinction in Civic Engagement and Renewal award from the National September 11 Memorial & Museum. This honor recognizes his contributions to the Memorial's mission, particularly in commemorating the victims of the 9/11 attacks. Alexandria will also participate in the 9/11 Tribute in Lights on September 11, lighting up its NYC campus in 'Memorial Blue'. The company maintains a strong commitment to social impact, addressing key societal issues such as health and food insecurity.
Alexandria Real Estate Equities declared a quarterly cash dividend of $1.12 per common share for Q3 2021, payable on October 15, 2021. This brings the total dividend for the year to $4.42, representing a 6 percent increase from the previous year. The funds from operations payout ratio remains low at 60 percent, indicating strong cash management and growth potential. The company continues to invest in its Class A properties, ensuring sustainable growth.
Alexandria Real Estate Equities (NYSE: ARE) will host a conference call and audio webcast on October 26, 2021, at 3:00 p.m. ET to discuss its third quarter operating and financial results. The results will be released after market close on October 25, 2021. Interested participants can join the call by dialing (833) 366-1125 in the U.S. or (412) 902-6738. A replay will be available from 5:00 p.m. ET on October 26, through November 2, 2021. Alexandria specializes in urban office REITs focused on life sciences and technology campuses.
On July 26, 2021, Alexandria Real Estate Equities (ARE) reported strong financial results for Q2 2021. Total revenues increased by 16.6% to $509.6 million, and net income attributable to common stockholders rose to $380.6 million, up from $226.6 million YoY. The company enjoyed historic leasing activity, with 1.9 million RSF leased and rental rate increases of 42.4%. A strong balance sheet was highlighted with $4.5 billion in liquidity, and tenant collections reached 99.4%. Alexandria continues its strategic growth, focusing on life sciences with significant ongoing and future development projects.